EGFR+ NSCLC Breakthrough: MARIPOSA & COCOON Trials
Landmark Lung Cancer Trials point to New Treatment Standards and Improved Patient Care Published May 10, 2025 Two pivotal clinical trials, MARIPOSA and COCOON, unveiled at the European Lung cancer Congress (ELCC) 2025, are poised to reshape the treatment landscape for patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC). The MARIPOSA trial demonstrated a … Read more